تعلن الشركة السعودية للصناعات الدوائية والمستلزمات الطبية (سبيماكو الدوائية) عن قبول استقالة رئيس مجلسها، وتعيين رئيساً جديدأ لمجلس الإدارة.

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO ADDWAIEH) announces accepting the resignation of Chairman of Board and Appointment of a new Chairman. 2070 SPIMACO -0.60 % 1445/04/25     09/11/2023 08:20:42 Introduction Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO ADDWAIEH) announces the Board of Directors’ resolution pursuant to its meeting convened on 24/04/1445H corresponding to 08/11/2023G accepted the resignation of the Board Chairman His Excellency Mr. Mohammed bin Talal Alnahas (Non-Executive), effective as of 24/4/1445H corresponding to 08/11/2023G, based on his preferences, and Appointed Dr.Ahmed bin Hamdan Aljedai as Chairman of the Board, effective as of 25/04/1445H corresponding to 09/11/2023G, until the end of the current Board Cycle. The board of directors extend their sincere thanks and appreciation to His Excellency Mr. Mohammed bin Talal Alnahas Resigned Member Name His Excellency Mr. Mohammed bin Talal Alnahas Membership Type Non- Executive Resignation Submission Date 2023-11-08 Corresponding to 1445-04-24 Resignation Acceptance Date 2023-11-08 Corresponding to 1445-04-24 Resignation Effective Date 2023-11-08 Corresponding to 1445-04-24 Membership Starting Date for the Resigned Member 2022-04-03 Corresponding to 1443-09-02 Reasons of Resignation Based on his preferences Appointed Member Name Dr. Ahmed Hamdan Aljedai Membership Type Independent Membership Start Date 2023-11-09 Corresponding to 1445-04-25 Brief Resume of the Appointed Member Dr. Ahmed Hamdan Aljedai is Founding President, Saudi Society of Clinical Pharmacy (SSCP), Assistant Deputy Minister for Therapeutic Affairs in Ministry of Health, he is a Professor in College of Medicine & Pharmacy in Alfaisal University, and Adjunct Professor in College of Pharmacy in Al Qassim University. He holds PhD in Pharmacy from University of Health Sciences & Pharmacy - St. Louis, Missouri, USA. He also holds a master’s degree in business administration from Harlington University - UK. Date of Board Meeting in which Appointed New Member(s) were Appointed 2023-11-08 Corresponding to 1445-04-24 Board Approval Board Approval May not be Deemed Final, this Appointment Shall Be Put before the First General Assembly Meeting for Approval The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. Share Previous Announcements Saudi Pharmaceutical Industries and Medical Appliances Corp. announces the board of director’s recommendation to distribute cash dividends for the fiscal year 2025 Saudi Pharmaceutical Industries and Medical Appliances Corp. announces the board of director’s recommendation to distribute cash dividends for the fiscal year 2025 2070 SPIMACO -0.60 % 1447/10/12     31/03/2026 08:17:49 Saudi Pharmaceutical Industries and Medical Appliances Corp. announces its Annual Financial results for the period ending on 2025-12-31 Saudi Pharmaceutical Industries and Medical Appliances Corp. announces its Annual Financial results for the period ending on 2025-12-31 2070 SPIMACO -0.60 % 1447/10/12     31/03/2026 07:47:35 The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) announces the establishment of a fully owned subsidiary, SPIMACO Bio, specialized in the development and manufacturing of biopharmaceutical products. The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) announces the establishment of a fully owned subsidiary, SPIMACO Bio, specialized in the development and manufacturing of biopharmaceutical products. 2070 SPIMACO -0.60 % 1447/07/15     04/01/2026 09:27:05 View all announcements Company Performance SPIMACO Add To Watchlist In your Watchlist Add To Watchlist Zoom 1D 1M 3M 1Y 3Y 5Y Inception Created with Highcharts 10.0.0 Highcharts Stock Responsive Chart Click small/large buttons or change window size to test responsiveness 10:15 10:30 10:45 10:30 29.45 29.5 29.55 29.6 29.65 29.7 29.75 29.8 Zoom Zoom ▾ 1M 3M 1Y 3Y 5Y Inception Apr 12, 2026 → Apr 12, 2026 Key Parameters Last Price 29.64 Net Change -0.18 (-0.6%) Value Traded (Sar) 2,016,294.24 Volume Traded 68,061 See The Company Profile Upcoming Calendar Dates 2070 SPIMACO | 2099-03-06 2070 SPIMACO | 2098-03-18 2070 SPIMACO | 2097-04-13 LoginPortletPopupv2 /wps/contenthandler/!ut/p/digest!wAJqgaTYTUod5sxoqfnrow/pm/oid:--portletwindowid--@oid:Z6_5A602H80O0HTC060SG6UT81DI3 /wps/contenthandler/!ut/p/digest!wAJqgaTYTUod5sxoqfnrow/um/secure/currentuser/profile?expandRefs=true Log in to access your watchlist Error Here Error Here Log In Don't Have Account? Register Here Forgot Password? Forgot Password Error Submit Welcome Please select a mode of authentication SMS Verification (OTP) Sent Email Verification (OTP) Sent to Error Send OTP Enter OTP OTP is not valid Confirm Resend AddtoWatchlistv2 NO PORTLET SESSION YET